Advocacy intelligence hub — real-time data for patient organizations
Minghui Pharmaceutical (Hangzhou) Ltd — PHASE3
Amgen — PHASE2
Minghui Pharmaceutical (Hangzhou) Ltd — PHASE3
Sheba Medical Center — PHASE4
Innovent Biologics (Suzhou) Co. Ltd. — PHASE4
Zai Lab (Shanghai) Co., Ltd. — PHASE3
Peking University Third Hospital — NA
Innovent Biologics (Suzhou) Co. Ltd. — PHASE3
Minghui Pharmaceutical (Hangzhou) Ltd — PHASE3
Viridian Therapeutics, Inc. — PHASE3
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Hélène Dollfus, MD
Fédération Génétique
Michele C Walsh, MD
Case Western Reserve University, Rainbow Babies and Children's Hospital
Dr Samarendra Mohanty
Nanoscope Therapeutics Inc.
Mitul Mehta, MD, MD
University of California, Irvine/Gavin Herbert Eye Institute
📍 IRVINE, CA
Sheikh Riazuddin, PhD
Jinnah Burn and Reconstructive Surgery Center (JB&RSC), Lahore
Ronald Goldwater, MD
PAREXEL Early Phase Clinical Unit Baltimore